Literature DB >> 21245683

Breast cancer screening in women aged 50-74 years: is there room for improvement?

Jean-François Morère1, Xavier Pivot, Jérôme Viguier, Jean-Yves Blay, Anne Calazel-Benque, Yvan Coscas, Claire Roussel, François Eisinger.   

Abstract

Regular mammography screening has been available in France, free of charge, for all women aged 50-74 years since 2005. Two nationwide surveys [EDIFICE 1 (507 women interviewed; age 50-74 years) and EDIFICE 2 (488 women)] recently collected data on individuals' access to cancer screening procedures. Two further surveys interviewed 600 general practitioners (GPs) each to determine their attitudes towards screening in general and screening for breast cancer in particular. The method of quotas ensured the populations surveyed were representative. In 2005, 93%, and in 2008, 94% of women reported having undergone a screening mammography. Anage-related effect was apparent in the 70-74 year subgroup in 2005, whereas in 2008, over 90% of women aged 50-74 years had had a mammography in their lifetime. In 2008, 66% of women had undergone a mammography as a part of an organized screening programme, versus 45% in 2005. In 2005, 15% of women reported having received no recommendation from their GP, whereas this figure fell to 4% in 2008. In both EDIFICE surveys, two thirds of GPs systematically recommended breast cancer screening to female patients aged 50-74 years; however, female GPs were more likely to systematically recommend this screening. In 2008, 77% of the GPs questioned were aware of the recommended frequency for breast cancer screening, compared with 71% in 2005. Results of studies such as EDIFICE may help increase the proportion of women who undergo breast cancer screening. Successful implementation of organized screening relies heavily on treating physicians. The impact of mammography in breast cancer screening may be further improved by systematic organized screening, by encouraging regular examination and by targeting women who give up screening.

Entities:  

Mesh:

Year:  2011        PMID: 21245683     DOI: 10.1097/01.cej.0000391562.18512.4a

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  4 in total

1.  Women's participation in breast cancer screening in France--an ethical approach.

Authors:  Grégoire Moutel; Nathalie Duchange; Sylviane Darquy; Sandrine de Montgolfier; Frédérique Papin-Lefebvre; Odile Jullian; Jérôme Viguier; Hélène Sancho-Garnier
Journal:  BMC Med Ethics       Date:  2014-08-16       Impact factor: 2.652

2.  Does the Neighborhood Area of Residence Influence Non-Attendance in an Urban Mammography Screening Program? A Multilevel Study in a Swedish City.

Authors:  Magdalena Lagerlund; Juan Merlo; Raquel Pérez Vicente; Sophia Zackrisson
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

3.  From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).

Authors:  S Couraud; A B Cortot; L Greillier; V Gounant; B Mennecier; N Girard; B Besse; L Brouchet; O Castelnau; P Frappé; G R Ferretti; L Guittet; A Khalil; P Lefebure; F Laurent; S Liebart; O Molinier; E Quoix; M-P Revel; B Stach; P-J Souquet; P Thomas; J Trédaniel; E Lemarié; G Zalcman; F Barlési; B Milleron
Journal:  Ann Oncol       Date:  2012-11-07       Impact factor: 32.976

4.  Patient and physician characteristics affect adherence to screening mammography: A population-based cohort study.

Authors:  Daniela Katz; Angela J Tengekyon; Natan R Kahan; Ronit Calderon-Margalit
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.